Cold atmospheric plasma treatment for diaper dermatitis: A case report

2021 ◽  
Author(s):  
Chenchen Zhang ◽  
Jun Zhao ◽  
Yamei Gao ◽  
Jing Gao ◽  
Yongmei Lv
2020 ◽  
Vol 19-20 ◽  
pp. 100105
Author(s):  
Minh Dinh Nguyen ◽  
Quynh Thi Do ◽  
Thanh-Tu Luong ◽  
Ngoc-Thanh Le ◽  
Tran-Thuy Nguyen ◽  
...  

2014 ◽  
Vol 34 (4) ◽  
pp. 941-946 ◽  
Author(s):  
RAFAEL GUERRERO-PRESTON ◽  
TAKENORI OGAWA ◽  
MAMORU UEMURA ◽  
GARY SHUMULINSKY ◽  
BLANCA L. VALLE ◽  
...  

2018 ◽  
Vol 400 (1) ◽  
pp. 111-122 ◽  
Author(s):  
Christin Schneider ◽  
Stephanie Arndt ◽  
Julia L. Zimmermann ◽  
Yangfang Li ◽  
Sigrid Karrer ◽  
...  

AbstractPlasma oncology is a relatively new field of research. Recent developments have indicated that cold atmospheric plasma (CAP) technology is an interesting new therapeutic approach to cancer treatment. In this study, p53 wildtype (LoVo) and human p53 mutated (HT29 and SW480) colorectal cancer cells were treated with the miniFlatPlaSter – a device particularly developed for the treatment of tumor cells – that uses the Surface Micro Discharge (SMD) technology for plasma production in air. The present study analyzed the effects of plasma on colorectal cancer cellsin vitroand on normal colon tissueex vivo. Plasma treatment had strong effects on colon cancer cells, such as inhibition of cell proliferation, induction of cell death and modulation of p21 expression. In contrast, CAP treatment of murine colon tissueex vivofor up to 2 min did not show any toxic effect on normal colon cells compared to H2O2positive control. In summary, these results suggest that the miniFlatPlaSter plasma device is able to kill colorectal cancer cells independent of their p53 mutation status. Thus, this device presents a promising new approach in colon cancer therapy.


2015 ◽  
Vol 13 (4) ◽  
pp. 410-418 ◽  
Author(s):  
Elliot A. J. Bartis ◽  
Pingshan Luan ◽  
Andrew J. Knoll ◽  
David B. Graves ◽  
Joonil Seog ◽  
...  

2019 ◽  
Vol 301 ◽  
pp. 125281 ◽  
Author(s):  
Ewa Wielogorska ◽  
Yusuf Ahmed ◽  
Julie Meneely ◽  
William G. Graham ◽  
Christopher T. Elliott ◽  
...  

2020 ◽  
Author(s):  
N. Redzuan ◽  
M. R. Rabbi ◽  
L. Agun ◽  
N. Ahmad ◽  
K. Zakaria ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Gillian E. Conway ◽  
Zhonglei He ◽  
Ana Lacramioara Hutanu ◽  
George Paul Cribaro ◽  
Eline Manaloto ◽  
...  

Abstract Room temperature Cold Atmospheric Plasma (CAP) has shown promising efficacy for the treatment of cancer but the exact mechanisms of action remain unclear. Both apoptosis and necrosis have been implicated as the mode of cell death in various cancer cells. We have previously demonstrated a caspase-independent mechanism of cell death in p53-mutated glioblastoma multiforme (GBM) cells exposed to plasma. The purpose of this study was to elucidate the molecular mechanisms involved in caspase-independent cell death induced by plasma treatment. We demonstrate that plasma induces rapid cell death in GBM cells, independent of caspases. Accumulation of vesicles was observed in plasma treated cells that stained positive with acridine orange. Western immunoblotting confirmed that autophagy is not activated following plasma treatment. Acridine orange intensity correlates closely with the lysosomal marker Lyso TrackerTM Deep Red. Further investigation using isosurface visualisation of confocal imaging confirmed that lysosomal accumulation occurs in plasma treated cells. The accumulation of lysosomes was associated with concomitant cell death following plasma treatment. In conclusion, we observed rapid accumulation of acidic vesicles and cell death following CAP treatment in GBM cells. We found no evidence that either apoptosis or autophagy, however, determined that a rapid accumulation of late stage endosomes/lysosomes precedes membrane permeabilisation, mitochondrial membrane depolarisation and caspase independent cell death.


Sign in / Sign up

Export Citation Format

Share Document